Efficacy of Personalized Postoperative Epilepsy Management in Patients with Glioblastoma Utilizing IDH1 Gene Assessment

References

• Ostrom QT, Price M, Neff C, et al. CBTRUS Statistical Report: primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019. Neuro Oncol. 2022;24(Suppl 5):v1–v95. doi:10.1093/neuonc/noac202
   PubMedGoogle Scholar
• Nabors LB, Portnow J, Ahluwalia M, et al. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(11):1537–1570. doi:10.6004/jnccn.2020.0052
   PubMed Web of Science ®Google Scholar
• Lange F, Hörnschemeyer J, Kirschstein T. Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy. Cells. 2021;10(5):1226. doi:10.3390/cells10051226
   PubMed Web of Science ®Google Scholar
• Pallud J, Le Van Quyen M, Bielle F, et al. Cortical GABAergic excitation contributes to epileptic activities around human glioma. Sci Transl Med. 2014;6(244):244ra89. doi:10.1126/scitranslmed.3008065
   PubMed Web of Science ®Google Scholar
• Venkatesh HS, Johung TB, Caretti V, et al. Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion. Cell. 2015;161(4):803–816. doi:10.1016/j.cell.2015.04.012
   PubMed Web of Science ®Google Scholar
• Wang Y, Qian T, You G, et al. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. Neuro Oncol. 2015;17(2):282–288. doi:10.1093/neuonc/nou130
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Patil N, Barnholtz-Sloan JS, et al. CBTRUS Statistical Report: primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. Neuro Oncol. 2020;22(12 Suppl 2):iv1–iv96. doi:10.1093/neuonc/noaa200
   PubMed Web of Science ®Google Scholar
• Jiang T, Nam DH, Wang Q, et al. Clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2021;499:60–72. doi:10.1016/j.canlet.2020.10.050
   PubMed Web of Science ®Google Scholar
• Le VH, Minh TNT, Le NQK, et al. A transfer learning approach on MRI-based radiomics signature for overall survival prediction of low-grade and high-grade gliomas. Med Biol Eng Comput. 2023;61(10):2699–2712. doi:10.1007/s11517-023-02875-2
   PubMedGoogle Scholar
• Lam LHT, Chu NT, Le NQK, et al. A Radiomics-Based Machine Learning Model for Prediction of Tumor Mutational Burden in Lower-Grade Gliomas. Cancers. 2022;14(14):3492. doi:10.3390/cancers14143492
   PubMed Web of Science ®Google Scholar
• Shan X, Fan X, Jiang T, et al. Clinical characteristics associated with postoperative seizure control in adult low-grade gliomas: a systematic review and meta-analysis. Neuro Oncol. 2018;20(3):324–331. doi:10.1093/neuonc/nox130
   PubMed Web of Science ®Google Scholar
• Liang S, Fan X, Jiang T, et al. Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma-related epilepsy. Cancer Med. 2019;8(10):4527–4535. doi:10.1002/cam4.2362
   PubMed Web of Science ®Google Scholar
• Shin JY, Kizilbash SH, Robinson SI, et al. Seizures in patients with primary brain tumors: what is their psychosocial impact? J Neurooncol. 2016;128(2):285–291. doi:10.1007/s11060-016-2108-y
   PubMed Web of Science ®Google Scholar
• Song L, Quan X, Chen C, et al. Correlation Between Tumor Molecular Markers and Perioperative Epilepsy in Patients With Glioma: a Systematic Review and Meta-Analysis. Front Neurol. 2021;12:692751. doi:10.3389/fneur.2021.692751
   PubMed Web of Science ®Google Scholar
• Li L, Li G, Jiang T, et al. New-Onset Postoperative Seizures in Patients With Diffuse Gliomas: a Risk Assessment Analysis. Front Neurol. 2021;12:682535. doi:10.3389/fneur.2021.682535
   PubMed Web of Science ®Google Scholar
• Yan H, Parsons DW, Bigner DD, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360(8):765–773. doi:10.1056/NEJMoa0808710
   PubMed Web of Science ®Google Scholar
• Parsons DW, Jones S, Kinzler KW, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897):1807–1812. doi:10.1126/science.1164382
   PubMed Web of Science ®Google Scholar
• Bleeker FE, Lamba S, Bardelli A, et al. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat. 2009;30(1):7–11. doi:10.1002/humu.20937
   PubMed Web of Science ®Google Scholar
• Liang R, Fan Y, Liu Y, et al. The significance of IDH1 mutations in tumor-associated seizure in 60 Chinese patients with low-grade gliomas. ScientificWorldJournal. 2013;2013:403942. doi:10.1155/2013/403942
   PubMedGoogle Scholar
• Stockhammer F, Misch M, Hartmann C, et al. IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom. Seizure. 2012;21(3):194–197. doi:10.1016/j.seizure.2011.12.007
   PubMed Web of Science ®Google Scholar
• Fathi AT, Nahed BV, Chi AS, et al. Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma. Oncologist. 2016;21(2):214–219. doi:10.1634/theoncologist.2015-0342
   PubMed Web of Science ®Google Scholar
• Chen H, Judkins J, Horbinski C, et al. Mutant IDH1 and seizures in patients with glioma. Neurology. 2017;88(19):1805–1813. doi:10.1212/WNL.0000000000003911
   PubMed Web of Science ®Google Scholar
• Lim JS, Kim WI, Lee JH, et al. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med. 2015;21(4):395–400. doi:10.1038/nm.3824
   PubMed Web of Science ®Google Scholar
• Albrecht J, Zielińska M. Mechanisms of Excessive Extracellular Glutamate Accumulation in Temporal Lobe Epilepsy. Neurochem Res. 2017;42(6):1724–1734. doi:10.1007/s11064-016-2105-8
   PubMed Web of Science ®Google Scholar
• Mortazavi A, Fayed I, Zaghloul KA, et al. IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation. Neuro Oncol. 2022;24(9):1423–1435. doi:10.1093/neuonc/noac003
   PubMed Web of Science ®Google Scholar
• Englot DJ, Chang EF, Vecht CJ. Epilepsy and brain tumors. Handb Clin Neurol. 2016;134:267–285. doi:10.1016/B978-0-12-802997-8.00016-5
   PubMedGoogle Scholar
• Liang S, Zhang J, Fu X, et al. Epilepsy in Adults with Supratentorial Glioblastoma: incidence and Influence Factors and Prophylaxis in 184 Patients. PLoS One. 2016;11(7):e0158206. doi:10.1371/journal.pone.0158206
   PubMed Web of Science ®Google Scholar
• Armstrong TS, Grant R, Norden AD, et al. Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. Neuro Oncol. 2016;18(6):779–789. doi:10.1093/neuonc/nov269
   PubMed Web of Science ®Google Scholar